ADN1.DEADN1.DEXETRA
Loading
EBITDA Over TimeExpanding
Percentile Rank93
3Y CAGR-0.5%
5Y CAGR+16.0%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-0.5%/yr
vs +41.9%/yr prior
5Y CAGR
+16.0%/yr
Recent deceleration
Acceleration
-42.4pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$101.43M+23.1%
2023$82.43M-11.7%
2022$93.32M-9.4%
2021$102.99M+70.3%
2020$60.48M+25.1%
2019$48.33M+46.6%
2018$32.98M+29.8%
2017$25.40M+8.3%
2016$23.46M+60.2%
2015$14.64M-